Development and validation of prognostic nomogram for T1-3N0M0 non-small cell lung cancer after curative resection

被引:2
|
作者
Mei, Weijian [1 ]
Yao, Wang [2 ]
Song, Zhengbo [3 ]
Jiao, Wenjie [4 ]
Zhu, Lianxin [5 ,6 ]
Huang, Qinghua [7 ]
An, Chaolun [8 ]
Shi, Jianguang [9 ]
Yu, Guiping [10 ]
Sun, Pingli [11 ]
Zhang, Yinbin [12 ]
Shen, Jianfei [13 ]
Xu, Chunwei [14 ]
Yang, Han [1 ]
Wang, Qian [14 ]
Zhu, Zhihua [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Thorac Surg, State Key Lab Oncol South China,Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China
[3] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China
[4] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao, Peoples R China
[5] Nanchang Univ, Med Coll, Nanchang, Peoples R China
[6] Queen Mary Univ London, London, England
[7] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Nanning, Peoples R China
[8] Nantong Univ, Nantong Peoples Hosp 3, Dept Thorac Surg, Nantong, Peoples R China
[9] Zhejiang Univ, Ningbo Hosp 1, Dept Thorac Surg, Ningbo, Peoples R China
[10] Southeast Univ, Affiliated Jiangyin Hosp, Dept Thorac Surg, Jiangyin, Peoples R China
[11] Jilin Univ, Hosp 2, Dept Pathol Dept, Changchun, Peoples R China
[12] Xi An Jiao Tong Univ, Affiliated Hosp 2, Med Coll, Dept Thorac Surg, Xian, Peoples R China
[13] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Thorac Surg, Taizhou, Peoples R China
[14] Nanjing Univ Chinese Med, Suqian Hosp Chinese Med, Affiliated Hosp, Dept Resp Med, 9 Hongzehu Dong Rd, Suqian 223800, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Non-small cell lung cancer; Nomogram; Curative resection; SURVIVAL; LOBECTOMY; QUALITY;
D O I
10.1186/s12885-023-11158-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundRadical resection plus lymph node dissection is a common treatment for patients with T1-3N0M0 non-small cell lung cancer (NSCLC). Few models predicted the survival outcomes of these patients. This study aimed to developed a nomogram for predicting their overall survival (OS).Materials and methodsThis study involved 3002 patients with T1-3N0M0 NSCLC after curative resection between January 1999 and October 2013. 1525 Patients from Sun Yat-sen University Cancer Center were randomly allocated to training cohort and internal validation cohort in a ratio of 7:3. 1477 patients from ten institutions were recruited as external validation cohort. A nomogram was constructed based on the training cohort and validated by internal and external validation cohort to predict the OS of these patients. The accuracy and practicability were tested by Harrell's C-indexes, calibration plots and decision curve analyses (DCA).ResultsAge, sex, histological classification, pathological T stage, and HI standard were independent factors for OS and were included in our nomogram. The C-index of the nomogram for OS estimates were 0.671 (95% CI, 0.637-0.705),0.632 (95% CI, 0.581-0.683), and 0.645 (95% CI, 0.617-0.673) in the training cohorts, internal validation cohorts, and external validation cohort, respectively. The calibration plots and DCA for predictions of OS were in excellent agreement. An online version of the nomogram was built for convenient clinical practice.ConclusionsOur nomogram can predict the OS of patients with T1-3N0M0 NSCLC after curative resection. The online version of our nomogram offer opportunities for fast personalized risk stratification and prognosis prediction in clinical practice.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Local failure after complete resection of N0-1 non-small cell lung cancer
    Saynak, Mert
    Veeramachaneni, Nirmal K.
    Hubbs, Jessica L.
    Nam, Jiho
    Qaqish, Bahjat F.
    Bailey, Janet E.
    Chung, Wonil
    Marks, Lawrence B.
    LUNG CANCER, 2011, 71 (02) : 156 - 165
  • [22] SURGERY PLUS ADJUVANT CHEMOTHERAPY FOR T1-3N0M0 SMALL-CELL LUNG-CANCER - RATIONALE FOR CURRENT APPROACH
    MACCHIARINI, P
    HARDIN, M
    BASOLO, F
    BRUNO, J
    CHELLA, A
    ANGELETTI, CA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (03): : 218 - 224
  • [23] Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Sanuki, Naoko
    Nishimura, Shuichi
    Takagawa, Yoshiaki
    Enomoto, Tatsuji
    Saeki, Noriyuki
    Yashiro, Kae
    Mizuno, Tomikazu
    Aoki, Yousuke
    Oku, Yohei
    Yokosuka, Tetsuya
    Shigematsu, Naoyuki
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (03) : 265 - 272
  • [24] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [25] Overall Survival (OS) of Pathological T1N0 Non-Small Cell Lung Cancer (NSCLC) After Resection
    Bourdages-Pageau, E.
    Vieira, A.
    Labbe, C.
    Figueroa, P. Ugalde
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2410 - S2411
  • [26] Wedge resection before lobectomy for patients with T1N0M0 non-small cell lung cancer: a propensity score matching analysis
    Zeng, Yuan
    Huang, Ying
    Fu, Junhui
    Xu, Ke
    Liang, Wenhua
    Cui, Fei
    Hao, Zhexue
    Li, Xukai
    Xing, Tuo
    He, Jianxing
    Liu, Jun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (09)
  • [27] Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
    Li, Ming
    Yang, Xiaodong
    Chen, Yuhan
    Yang, Xinyu
    Dai, Xiyu
    Sun, Fenghao
    Zhang, Li
    Zhan, Cheng
    Feng, Mingxiang
    Wang, Qun
    ONCOTARGETS AND THERAPY, 2017, 10 : 2885 - 2892
  • [28] Comparison of segmentectomy and wedge resection for cT1cN0M0 non-small cell lung cancer
    Takamori, Satoshi
    Endo, Makoto
    Suzuki, Jun
    Watanabe, Hikaru
    Shiono, Satoshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2025, 73 (02) : 110 - 117
  • [29] Comparison of segmentectomy and wedge resection for cT1cN0M0 non-small cell lung cancer
    Takamori, Satoshi
    Nakatsuka, Marina
    Endo, Makoto
    Shiono, Satoshi
    RESPIROLOGY, 2024, 29 : 40 - 40
  • [30] Impact of Inflammation and Sarcopenia on Outcomes after Stereotactic Body Radiotherapy for T1N0M0 Non-Small Cell Lung Cancer
    Matsuo, Yukinori
    Nagata, Yasushi
    Wakabayashi, Masashi
    Eba, Junko
    Ishikura, Satoshi
    Onishi, Hiroshi
    Kokubo, Masaki
    Karasawa, Katsuyuki
    Shioyama, Yoshiyuki
    Onimaru, Rikiya
    Hiraoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1062 - S1063